FDA CERSI Lecture Series

The CERSI Lecture series features presentations by investigators from all four CERSI academic institutions on current research in regulatory science. Below are the lectures presented by UCSF or Stanford faculty. For a complete listing of all CERSI Lectures, please visit the FDA’s CERSI Lecture Series website.

Speaker	Talk Title	Date
Christopher Almond, MD, MPH Stanford University	Pediatric Medical Devices - Challenges and Opportunities	07/25/2023
Esteban Burchard, MD, MPH University of California, San Francisco	Race & Genetic Ancestry in Medicine. A Time for Reckoning Racism	03/08/2022
Atul Butte, MD, PhD University of California, San Francisco	Precisely practicing medicine for COVID, from a half million tested patients and a trillion points of data	03/10/2021
Matthew Porteus, MD, PhD Stanford University	Streamlining Genetic Safety Analysis for Ex Vivo Genome Edited Cell Therapies: Creating Safe and Efficacious Cellular Drugs using Genome Editing	06/02/2020
Leslie Wilson, PhD University of California, San Francisco	Advances in Patient Preference Information to Enhance Benefit-Risk Assessment: Learning from Case Studies	10/02/2019
Joseph DeRisi, PhD University of California, San Francisco	Chan-Zuckerberg Biohub (Recording not available)	11/05/2018
Laura Esserman, MD, MBA University of California, San Francisco School of Medicine	OneSource Checklists: Tools for Integrating Care and Research and Catalyzing a Sea Change in the Practice of Medicine	09/12/2017
Steven Goodman, MD, MHS, PhD Stanford University	Reproducibility in Medicine and Science	05/11/2017
Joseph C. Wu, MD, PhD Stanford School of Medicine	Patient-Specific Stem Cells for Precision Medicine	12/08/2016
Christopher (Chris) Ré, PhD Stanford University	DeepDive: A Data System for Macroscopic Science	11/30/2016
Stephen Quake, PhD Stanford University	A Molecular Stethoscope	10/26/2016